-
1
-
-
0026049696
-
Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation
-
Zhang, H. et al. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 114, 155-167 (1991).
-
(1991)
J. Cell Biol
, vol.114
, pp. 155-167
-
-
Zhang, H.1
-
2
-
-
77953790503
-
An update on sphingosine-1-phosphate and other sphingolipid mediators
-
Fyrst, H. & Saba, J. D. An update on sphingosine-1-phosphate and other sphingolipid mediators. Nature Chem. Biol. 6, 489-497 (2010).
-
(2010)
Nature Chem. Biol
, vol.6
, pp. 489-497
-
-
Fyrst, H.1
Saba, J.D.2
-
3
-
-
79961082952
-
Translational aspects of sphingosine 1-phosphate biology
-
Pyne, S. & Pyne, N. J. Translational aspects of sphingosine 1-phosphate biology. Trends Mol. Med. 17, 463-472 (2011).
-
(2011)
Trends Mol. Med
, vol.17
, pp. 463-472
-
-
Pyne, S.1
Pyne, N.J.2
-
4
-
-
84868517918
-
Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: Review of sphingosine kinase inhibitors
-
Orr Gandy, K. A. & Obeid, L. M. Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors. Biochim. Biophys. Acta 1831, 157-166 (2013).
-
(2013)
Biochim. Biophys. Acta
, vol.1831
, pp. 157-166
-
-
Orr Gandy, K.A.1
Obeid, L.M.2
-
5
-
-
84855303523
-
Sphingosine-1-phosphate signaling and its role in disease
-
Maceyka, M., Harikumar, K. B., Milstien, S. & Spiegel, S. Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol. 22, 50-60 (2012).
-
(2012)
Trends Cell Biol
, vol.22
, pp. 50-60
-
-
MacEyka, M.1
Harikumar, K.B.2
Milstien, S.3
Spiegel, S.4
-
6
-
-
84878906549
-
Sphingosine-1-phosphate and its receptors: Structure, signaling, and influence
-
Rosen, H., Stevens, R. C., Hanson, M., Roberts, E. & Oldstone, M. B. Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. Annu. Rev. Biochem. 82, 637-662 (2013).
-
(2013)
Annu. Rev. Biochem
, vol.82
, pp. 637-662
-
-
Rosen, H.1
Stevens, R.C.2
Hanson, M.3
Roberts, E.4
Oldstone, M.B.5
-
7
-
-
77953966511
-
Sphingosine 1-phosphate and cancer
-
Pyne, N. J. & Pyne, S. Sphingosine 1-phosphate and cancer. Nature Rev. Cancer 10, 489-503 (2010).
-
(2010)
Nature Rev. Cancer
, vol.10
, pp. 489-503
-
-
Pyne, N.J.1
Pyne, S.2
-
8
-
-
79957610938
-
The outs and the ins of sphingosine-1-phosphate in immunity
-
Spiegel, S. & Milstien, S. The outs and the ins of sphingosine-1-phosphate in immunity. Nature Rev. Immunol. 11, 403-415 (2011).
-
(2011)
Nature Rev. Immunol
, vol.11
, pp. 403-415
-
-
Spiegel, S.1
Milstien, S.2
-
9
-
-
84859385704
-
Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs
-
Cyster, J. G. & Schwab, S. R. Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs. Annu. Rev. Immunol. 30, 69-94 (2012).
-
(2012)
Annu. Rev. Immunol
, vol.30
, pp. 69-94
-
-
Cyster, J.G.1
Schwab, S.R.2
-
10
-
-
0029948396
-
Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
-
Cuvillier, O. et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 381, 800-803 (1996).
-
(1996)
Nature
, vol.381
, pp. 800-803
-
-
Cuvillier, O.1
-
11
-
-
78049480679
-
Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis
-
Brinkmann, V. et al. Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis. Nature Rev. Drug Discov. 9, 883-897 (2010).
-
(2010)
Nature Rev. Drug Discov
, vol.9
, pp. 883-897
-
-
Brinkmann, V.1
-
12
-
-
77953923379
-
Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2
-
Alvarez, S. E. et al. Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465, 1084-1088 (2010).
-
(2010)
Nature
, vol.465
, pp. 1084-1088
-
-
Alvarez, S.E.1
-
13
-
-
69949113620
-
Regulation of histone acetylation in the nucleus by sphingosine-1- phosphate
-
Hait, N. C. et al. Regulation of histone acetylation in the nucleus by sphingosine-1-phosphate. Science 325, 1254-1257 (2009).
-
(2009)
Science
, vol.325
, pp. 1254-1257
-
-
Hait, N.C.1
-
14
-
-
79955770841
-
BACE1 activity is modulated by cell-associated sphingosine-1-phosphate
-
Takasugi, N. et al. BACE1 activity is modulated by cell-associated sphingosine-1-phosphate. J. Neurosci. 31, 6850-6857 (2011).
-
(2011)
J. Neurosci
, vol.31
, pp. 6850-6857
-
-
Takasugi, N.1
-
15
-
-
67649252344
-
Export and functions of sphingosine-1-phosphate
-
Kim, R. H., Takabe, K., Milstien, S. & Spiegel, S. Export and functions of sphingosine-1-phosphate. Biochim. Biophys. Acta 1791, 692-696 (2009).
-
(2009)
Biochim. Biophys. Acta
, vol.1791
, pp. 692-696
-
-
Kim, R.H.1
Takabe, K.2
Milstien, S.3
Spiegel, S.4
-
16
-
-
58849083220
-
The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors
-
Kawahara, A. et al. The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors. Science 323, 524-527 (2009).
-
(2009)
Science
, vol.323
, pp. 524-527
-
-
Kawahara, A.1
-
17
-
-
84874599020
-
Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network
-
Nagahashi, M. et al. Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network. FASEB J. 27, 1001-1011 (2013).
-
(2013)
FASEB J
, vol.27
, pp. 1001-1011
-
-
Nagahashi, M.1
-
18
-
-
84862188843
-
Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells
-
Hisano, Y., Kobayashi, N., Yamaguchi, A. & Nishi, T. Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells. PLoS ONE 7, e38941 (2012).
-
(2012)
PLoS ONE
, vol.7
-
-
Hisano, Y.1
Kobayashi, N.2
Yamaguchi, A.3
Nishi, T.4
-
19
-
-
84859727262
-
The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice
-
Fukuhara, S. et al. The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice. J. Clin. Invest. 122, 1416-1426 (2012).
-
(2012)
J. Clin. Invest
, vol.122
, pp. 1416-1426
-
-
Fukuhara, S.1
-
20
-
-
84870432809
-
The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate
-
Mendoza, A. et al. The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate. Cell Rep. 2, 1104-1110 (2012).
-
(2012)
Cell Rep
, vol.2
, pp. 1104-1110
-
-
Mendoza, A.1
-
21
-
-
79958257954
-
Lipid phosphate phosphatase 3 enables efficient thymic egress
-
Breart, B. et al. Lipid phosphate phosphatase 3 enables efficient thymic egress. J. Exp. Med. 208, 1267-1278 (2011).
-
(2011)
J. Exp. Med
, vol.208
, pp. 1267-1278
-
-
Breart, B.1
-
22
-
-
84872406787
-
Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer
-
Liang, J. et al. Sphingosine-1-phosphate links persistent STAT3 activation, chronic intestinal inflammation, and development of colitis-associated cancer. Cancer Cell 23, 107-120 (2013).
-
(2013)
Cancer Cell
, vol.23
, pp. 107-120
-
-
Liang, J.1
-
23
-
-
28544437478
-
Essential role for sphingosine kinases in neural and vascular development
-
Mizugishi, K. et al. Essential role for sphingosine kinases in neural and vascular development. Mol. Cell. Biol. 25, 11113-11121 (2005).
-
(2005)
Mol. Cell. Biol
, vol.25
, pp. 11113-11121
-
-
Mizugishi, K.1
-
24
-
-
38549152194
-
Principles of bioactive lipid signalling: Lessons from sphingolipids
-
Hannun, Y. A. & Obeid, L. M. Principles of bioactive lipid signalling: lessons from sphingolipids. Nature Rev. Mol. Cell. Biol. 9, 139-150 (2008).
-
(2008)
Nature Rev. Mol. Cell. Biol
, vol.9
, pp. 139-150
-
-
Hannun, Y.A.1
Obeid, L.M.2
-
25
-
-
78649982367
-
STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors
-
Lee, H. et al. STAT3-induced S1PR1 expression is crucial for persistent STAT3 activation in tumors. Nature Med. 16, 1421-1428 (2010).
-
(2010)
Nature Med
, vol.16
, pp. 1421-1428
-
-
Lee, H.1
-
26
-
-
84865159639
-
S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma
-
Liu, Y. et al. S1PR1 is an effective target to block STAT3 signaling in activated B cell-like diffuse large B-cell lymphoma. Blood 120, 1458-1465 (2012).
-
(2012)
Blood
, vol.120
, pp. 1458-1465
-
-
Liu, Y.1
-
27
-
-
84861399789
-
S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites
-
Deng, J. et al. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. Cancer Cell 21, 642-654 (2012).
-
(2012)
Cancer Cell
, vol.21
, pp. 642-654
-
-
Deng, J.1
-
28
-
-
84863057277
-
Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by tumor-induced angiogenesis and lymphangiogenesis
-
Nagahashi, M. et al. Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by tumor-induced angiogenesis and lymphangiogenesis. Cancer Res. 72, 726-735 (2012).
-
(2012)
Cancer Res
, vol.72
, pp. 726-735
-
-
Nagahashi, M.1
-
29
-
-
84864797320
-
Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis
-
Ponnusamy, S. et al. Communication between host organism and cancer cells is transduced by systemic sphingosine kinase 1/sphingosine 1-phosphate signalling to regulate tumour metastasis. EMBO Mol. Med. 4, 761-775 (2012).
-
(2012)
EMBO Mol. Med
, vol.4
, pp. 761-775
-
-
Ponnusamy, S.1
-
30
-
-
52949143502
-
Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer
-
Ruckhaberle, E. et al. Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer. Breast Cancer Res. Treat. 112, 41-52 (2008).
-
(2008)
Breast Cancer Res. Treat
, vol.112
, pp. 41-52
-
-
Ruckhaberle, E.1
-
31
-
-
59649086217
-
Role for sphingosine kinase 1 in colon carcinogenesis
-
Kawamori, T. et al. Role for sphingosine kinase 1 in colon carcinogenesis. FASEB J. 23, 405-414 (2008).
-
(2008)
FASEB J
, vol.23
, pp. 405-414
-
-
Kawamori, T.1
-
32
-
-
84888279260
-
Sphingosine 1-phosphate receptors and sphingosine kinase 1: Novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers
-
Pyne, S., Edwards, J., Ohotski, J. & Pyne, N. J. Sphingosine 1-phosphate receptors and sphingosine kinase 1: novel biomarkers for clinical prognosis in breast, prostate, and hematological cancers. Front. Oncol. 2, 168 (2012).
-
(2012)
Front. Oncol
, vol.2
, pp. 168
-
-
Pyne, S.1
Edwards, J.2
Ohotski, J.3
Pyne, N.J.4
-
33
-
-
51649122574
-
A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia
-
Paugh, S. W. et al. A selective sphingosine kinase 1 inhibitor integrates multiple molecular therapeutic targets in human leukemia. Blood 112, 1382-1391 (2008).
-
(2008)
Blood
, vol.112
, pp. 1382-1391
-
-
Paugh, S.W.1
-
34
-
-
82455192466
-
Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate
-
Kharel, Y. et al. Sphingosine kinase type 1 inhibition reveals rapid turnover of circulating sphingosine 1-phosphate. Biochem. J. 440, 345-353 (2011).
-
(2011)
Biochem. J
, vol.440
, pp. 345-353
-
-
Kharel, Y.1
-
35
-
-
84860812174
-
Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1
-
Schnute, M. E. et al. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1. Biochem. J. 444, 79-88 (2012).
-
(2012)
Biochem. J
, vol.444
, pp. 79-88
-
-
Schnute, M.E.1
-
36
-
-
80155127315
-
Sphingosine kinase inhibitors and cancer: Seeking the golden sword of Hercules
-
Pyne, S., Bittman, R. & Pyne, N. J. Sphingosine kinase inhibitors and cancer: seeking the golden sword of Hercules. Cancer Res. 71, 6576-6582 (2011).
-
(2011)
Cancer Res
, vol.71
, pp. 6576-6582
-
-
Pyne, S.1
Bittman, R.2
Pyne, N.J.3
-
37
-
-
84877253249
-
Molecular basis of sphingosine kinase 1 substrate recognition and catalysis
-
Wang, Z. et al. Molecular basis of sphingosine kinase 1 substrate recognition and catalysis. Structure 21, 798-809 (2013).
-
(2013)
Structure
, vol.21
, pp. 798-809
-
-
Wang, Z.1
-
38
-
-
84857873334
-
Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis
-
Chipuk, J. E. et al. Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis. Cell 148, 988-1000 (2012).
-
(2012)
Cell
, vol.148
, pp. 988-1000
-
-
Chipuk, J.E.1
-
39
-
-
84856745167
-
A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection
-
Gomez, L. et al. A novel role for mitochondrial sphingosine-1-phosphate produced by sphingosine kinase-2 in PTP-mediated cell survival during cardioprotection. Bas. Res. Cardiol. 106, 1341-1353 (2011).
-
(2011)
Bas. Res. Cardiol
, vol.106
, pp. 1341-1353
-
-
Gomez, L.1
-
40
-
-
79955068081
-
A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning
-
Vessey, D. A. et al. A sphingosine kinase form 2 knockout sensitizes mouse myocardium to ischemia/reoxygenation injury and diminishes responsiveness to ischemic preconditioning. Oxid. Med. Cell. Longev. 2011, 961059 (2011).
-
(2011)
Oxid. Med. Cell. Longev
, pp. 961059
-
-
Vessey, D.A.1
-
41
-
-
79551648970
-
Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration
-
Strub, G. M. et al. Sphingosine-1-phosphate produced by sphingosine kinase 2 in mitochondria interacts with prohibitin 2 to regulate complex IV assembly and respiration. FASEB J. 25, 600-612 (2011).
-
(2011)
FASEB J
, vol.25
, pp. 600-612
-
-
Strub, G.M.1
-
42
-
-
77949748845
-
Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2
-
French, K. J. et al. Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2. J. Pharmacol. Exp. Ther. 333, 129-139 (2010).
-
(2010)
J. Pharmacol. Exp. Ther
, vol.333
, pp. 129-139
-
-
French, K.J.1
-
43
-
-
78049490720
-
Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640
-
Antoon, J. W. et al. Antiestrogenic effects of the novel sphingosine kinase-2 inhibitor ABC294640. Endocrinology 151, 5124-5135 (2010).
-
(2010)
Endocrinology
, vol.151
, pp. 5124-5135
-
-
Antoon, J.W.1
-
44
-
-
84866379271
-
Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate
-
Kharel, Y. et al. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate. Biochem. J. 447, 149-157 (2012).
-
(2012)
Biochem. J
, vol.447
, pp. 149-157
-
-
Kharel, Y.1
-
45
-
-
38449084602
-
Cutting edge: Modulation of intestinal autoimmunity and IL-2 signaling by sphingosine kinase 2 independent of sphingosine 1-phosphate
-
Samy, E. T. et al. Cutting edge: modulation of intestinal autoimmunity and IL-2 signaling by sphingosine kinase 2 independent of sphingosine 1-phosphate. J. Immunol. 179, 5644-5648 (2007).
-
(2007)
J. Immunol
, vol.179
, pp. 5644-5648
-
-
Samy, E.T.1
-
46
-
-
77952236198
-
Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease
-
Maines, L. W., Fitzpatrick, L. R., Green, C. L., Zhuang, Y. & Smith, C. D. Efficacy of a novel sphingosine kinase inhibitor in experimental Crohn's disease. Inflammopharmacology 18, 73-85 (2010).
-
(2010)
Inflammopharmacology
, vol.18
, pp. 73-85
-
-
Maines, L.W.1
Fitzpatrick, L.R.2
Green, C.L.3
Zhuang, Y.4
Smith, C.D.5
-
47
-
-
77957770455
-
Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase
-
Chumanevich, A. A. et al. Suppression of colitis-driven colon cancer in mice by a novel small molecule inhibitor of sphingosine kinase. Carcinogenesis 31, 1787-1793 (2010).
-
(2010)
Carcinogenesis
, vol.31
, pp. 1787-1793
-
-
Chumanevich, A.A.1
-
48
-
-
77956894066
-
Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis
-
Baker, D. A., Barth, J., Chang, R., Obeid, L. M. & Gilkeson, G. S. Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis. J. Immunol. 185, 2570-2579 (2010).
-
(2010)
J. Immunol
, vol.185
, pp. 2570-2579
-
-
Baker, D.A.1
Barth, J.2
Chang, R.3
Obeid, L.M.4
Gilkeson, G.S.5
-
49
-
-
79958190513
-
Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase
-
Fitzpatrick, L. R. et al. Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase. Inflammopharmacology 19, 75-87 (2011).
-
(2011)
Inflammopharmacology
, vol.19
, pp. 75-87
-
-
Fitzpatrick, L.R.1
-
50
-
-
53249130741
-
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
-
Kazantsev, A. G. & Thompson, L. M. Therapeutic application of histone deacetylase inhibitors for central nervous system disorders. Nature Rev. Drug Discov. 7, 854-868 (2008).
-
(2008)
Nature Rev. Drug Discov
, vol.7
, pp. 854-868
-
-
Kazantsev, A.G.1
Thompson, L.M.2
-
51
-
-
57749170458
-
The many roles of histone deacetylases in development and physiology: Implications for disease and therapy
-
Haberland, M., Montgomery, R. L. & Olson, E. N. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nature Rev. Genet. 10, 32-42 (2009).
-
(2009)
Nature Rev. Genet
, vol.10
, pp. 32-42
-
-
Haberland, M.1
Montgomery, R.L.2
Olson, E.N.3
-
52
-
-
78449288141
-
Targeting the correct HDAC(s) to treat cognitive disorders
-
Fischer, A., Sananbenesi, F., Mungenast, A. & Tsai, L. H. Targeting the correct HDAC(s) to treat cognitive disorders. Trends Pharmacol. Sci. 31, 605-617 (2010).
-
(2010)
Trends Pharmacol. Sci
, vol.31
, pp. 605-617
-
-
Fischer, A.1
Sananbenesi, F.2
Mungenast, A.3
Tsai, L.H.4
-
53
-
-
84861430003
-
The Sjogren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway
-
Nakahara, K. et al. The Sjogren-Larsson syndrome gene encodes a hexadecenal dehydrogenase of the sphingosine 1-phosphate degradation pathway. Mol. Cell 46, 461-471 (2012).
-
(2012)
Mol. Cell
, vol.46
, pp. 461-471
-
-
Nakahara, K.1
-
54
-
-
84861003638
-
Truth and consequences of sphingosine-1-phosphate lyase
-
Aguilar, A. & Saba, J. D. Truth and consequences of sphingosine-1-phosphate lyase. Adv. Biol. Regul. 52, 17-30 (2012).
-
(2012)
Adv. Biol. Regul
, vol.52
, pp. 17-30
-
-
Aguilar, A.1
Saba, J.D.2
-
55
-
-
84867277218
-
Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts
-
Ihlefeld, K., Claas, R. F., Koch, A., Pfeilschifter, J. M. & Meyer Zu Heringdorf, D. Evidence for a link between histone deacetylation and Ca2+ homoeostasis in sphingosine-1-phosphate lyase-deficient fibroblasts. Biochem. J. 447, 457-464 (2012).
-
(2012)
Biochem. J
, vol.447
, pp. 457-464
-
-
Ihlefeld, K.1
Claas, R.F.2
Koch, A.3
Pfeilschifter, J.M.4
Meyer Zu Heringdorf, D.5
-
56
-
-
24644469502
-
Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients
-
Schwab, S. R. et al. Lymphocyte sequestration through S1P lyase inhibition and disruption of S1P gradients. Science 309, 1735-1739 (2005).
-
(2005)
Science
, vol.309
, pp. 1735-1739
-
-
Schwab, S.R.1
-
57
-
-
78650381368
-
Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: Discovery of (E)-1-(4-((1R,2S,3R)-1,2,3,4- tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932)
-
Bagdanoff, J. T. et al. Inhibition of sphingosine 1-phosphate lyase for the treatment of rheumatoid arthritis: discovery of (E)-1-(4-((1R,2S,3R)-1,2,3, 4-tetrahydroxybutyl)-1H-imidazol-2-yl)ethanone oxime (LX2931) and (1R,2S,3R)-1-(2-(isoxazol-3-yl)-1H-imidazol-4-yl)butane-1,2,3,4-tetraol (LX2932). J. Med. Chem. 53, 8650-8662 (2010).
-
(2010)
J. Med. Chem
, vol.53
, pp. 8650-8662
-
-
Bagdanoff, J.T.1
-
58
-
-
77955508596
-
Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism
-
Bourquin, F., Riezman, H., Capitani, G. & Grutter, M. G. Structure and function of sphingosine-1-phosphate lyase, a key enzyme of sphingolipid metabolism. Structure 18, 1054-1065 (2010).
-
(2010)
Structure
, vol.18
, pp. 1054-1065
-
-
Bourquin, F.1
Riezman, H.2
Capitani, G.3
Grutter, M.G.4
-
59
-
-
33746075255
-
Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling
-
Nagata, Y., Partridge, T. A., Matsuda, R. & Zammit, P. S. Entry of muscle satellite cells into the cell cycle requires sphingolipid signaling. J. Cell Biol. 174, 245-253 (2006).
-
(2006)
J. Cell Biol
, vol.174
, pp. 245-253
-
-
Nagata, Y.1
Partridge, T.A.2
Matsuda, R.3
Zammit, P.S.4
-
60
-
-
84861014560
-
Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway
-
Loh, K. C. et al. Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S1PR2/STAT3 signaling pathway. PLoS ONE 7, e37218 (2012).
-
(2012)
PLoS ONE
, vol.7
-
-
Loh, K.C.1
-
61
-
-
84870661131
-
Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila
-
Pantoja, M., Fischer, K. A., Ieronimakis, N., Reyes, M. & Ruohola-Baker, H. Genetic elevation of sphingosine 1-phosphate suppresses dystrophic muscle phenotypes in Drosophila. Development 140, 136-146 (2013).
-
(2013)
Development
, vol.140
, pp. 136-146
-
-
Pantoja, M.1
Fischer, K.A.2
Ieronimakis, N.3
Reyes, M.4
Ruohola-Baker, H.5
-
62
-
-
84857254248
-
Crystal structure of a lipid G protein-coupled receptor
-
Hanson, M. A. et al. Crystal structure of a lipid G protein-coupled receptor. Science 335, 851-855 (2012).
-
(2012)
Science
, vol.335
, pp. 851-855
-
-
Hanson, M.A.1
-
63
-
-
0037066466
-
Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists
-
Mandala, S. et al. Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science 296, 346-349 (2002).
-
(2002)
Science
, vol.296
, pp. 346-349
-
-
Mandala, S.1
-
64
-
-
0037077308
-
The immune modulator, FTY720, targets sphingosine 1-phosphate receptors
-
Brinkmann, V. et al. The immune modulator, FTY720, targets sphingosine 1-phosphate receptors. J. Biol. Chem. 277, 21453-21457 (2002).
-
(2002)
J. Biol. Chem
, vol.277
, pp. 21453-21457
-
-
Brinkmann, V.1
-
65
-
-
2442679391
-
The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors
-
Graler, M. H. & Goetzl, E. J. The immunosuppressant FTY720 down-regulates sphingosine 1-phosphate G protein-coupled receptors. FASEB J. 18, 551-553 (2004).
-
(2004)
FASEB J
, vol.18
, pp. 551-553
-
-
Graler, M.H.1
Goetzl, E.J.2
-
66
-
-
84856073375
-
S1P1 receptor modulation with cyclical recovery from lymphopenia ameliorates mouse model of multiple sclerosis
-
Gonzalez-Cabrera, P. J. et al. S1P1 receptor modulation with cyclical recovery from lymphopenia ameliorates mouse model of multiple sclerosis. Mol. Pharmacol. 81, 166-174 (2012).
-
(2012)
Mol. Pharmacol
, vol.81
, pp. 166-174
-
-
Gonzalez-Cabrera, P.J.1
-
67
-
-
34648832173
-
FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia
-
Neviani, P. et al. FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome-positive acute lymphocytic leukemia. J. Clin. Invest. 117, 2408-2421 (2007).
-
(2007)
J. Clin. Invest
, vol.117
, pp. 2408-2421
-
-
Neviani, P.1
-
68
-
-
84867319781
-
The selective S1P receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate: Translation from preclinical to clinical studies
-
Gergely, P. et al. The selective S1P receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate: translation from preclinical to clinical studies. Br. J. Pharmacol. 167, 1035-1047 (2012).
-
(2012)
Br. J. Pharmacol
, vol.167
, pp. 1035-1047
-
-
Gergely, P.1
-
69
-
-
84870459692
-
Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis
-
Komiya, T. et al. Efficacy and immunomodulatory actions of ONO-4641, a novel selective agonist for sphingosine 1-phosphate receptors 1 and 5, in preclinical models of multiple sclerosis. Clin. Exp. Immunol. 171, 54-62 (2013).
-
(2013)
Clin. Exp. Immunol
, vol.171
, pp. 54-62
-
-
Komiya, T.1
-
70
-
-
79955045614
-
The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation
-
Piali, L. et al. The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation. J. Pharmacol. Exp. Ther. 337, 547-556 (2011).
-
(2011)
J. Pharmacol. Exp. Ther
, vol.337
, pp. 547-556
-
-
Piali, L.1
-
71
-
-
84878311049
-
Fingolimod therapy for multiple sclerosis
-
Willis, M. A. & Cohen, J. A. Fingolimod therapy for multiple sclerosis. Semin. Neurol. 33, 37-44 (2013).
-
(2013)
Semin. Neurol
, vol.33
, pp. 37-44
-
-
Willis, M.A.1
Cohen, J.A.2
-
72
-
-
84873692322
-
Fingolimod treatment in multiple sclerosis leads to increased macular volume
-
Nolan, R., Gelfand, J. M. & Green, A. J. Fingolimod treatment in multiple sclerosis leads to increased macular volume. Neurology 80, 139-144 (2013).
-
(2013)
Neurology
, vol.80
, pp. 139-144
-
-
Nolan, R.1
Gelfand, J.M.2
Green, A.J.3
-
73
-
-
84866690914
-
A potent and selective S1P1 antagonist with efficacy in experimental autoimmune encephalomyelitis
-
Quancard, J. et al. A potent and selective S1P1 antagonist with efficacy in experimental autoimmune encephalomyelitis. Chem. Biol. 19, 1142-1151 (2012).
-
(2012)
Chem. Biol
, vol.19
, pp. 1142-1151
-
-
Quancard, J.1
-
74
-
-
79551674537
-
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
-
Choi, J. W. et al. FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation. Proc. Natl Acad. Sci. USA 108, 751-756 (2011).
-
(2011)
Proc. Natl Acad. Sci. USA
, vol.108
, pp. 751-756
-
-
Choi, J.W.1
-
75
-
-
33746365908
-
Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo
-
Sanna, M. G. et al. Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo. Nature Chem. Biol. 2, 434-441 (2006).
-
(2006)
Nature Chem. Biol
, vol.2
, pp. 434-441
-
-
Sanna, M.G.1
-
76
-
-
80052940381
-
Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection
-
Teijaro, J. R. et al. Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection. Cell 146, 980-991 (2011).
-
(2011)
Cell
, vol.146
, pp. 980-991
-
-
Teijaro, J.R.1
-
77
-
-
0037739755
-
A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells
-
Matsuoka, Y., Nagahara, Y., Ikekita, M. & Shinomiya, T. A novel immunosuppressive agent FTY720 induced Akt dephosphorylation in leukemia cells. Br. J. Pharmacol. 138, 1303-1312 (2003).
-
(2003)
Br. J. Pharmacol
, vol.138
, pp. 1303-1312
-
-
Matsuoka, Y.1
Nagahara, Y.2
Ikekita, M.3
Shinomiya, T.4
-
78
-
-
38049166147
-
FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma
-
Liu, Q. et al. FTY720 demonstrates promising preclinical activity for chronic lymphocytic leukemia and lymphoblastic leukemia/lymphoma. Blood 111, 275-284 (2008).
-
(2008)
Blood
, vol.111
, pp. 275-284
-
-
Liu, Q.1
-
79
-
-
77954376747
-
Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers
-
Roberts, K. G. et al. Essential requirement for PP2A inhibition by the oncogenic receptor c-KIT suggests PP2A reactivation as a strategy to treat c-KIT+ cancers. Cancer Res. 70, 5438-5447 (2010).
-
(2010)
Cancer Res
, vol.70
, pp. 5438-5447
-
-
Roberts, K.G.1
-
80
-
-
84862909353
-
The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways
-
Wang, Z., Jiang, H., Chen, S., Du, F. & Wang, X. The mitochondrial phosphatase PGAM5 functions at the convergence point of multiple necrotic death pathways. Cell 148, 228-243 (2012).
-
(2012)
Cell
, vol.148
, pp. 228-243
-
-
Wang, Z.1
Jiang, H.2
Chen, S.3
Du, F.4
Wang, X.5
-
81
-
-
84862907788
-
Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase
-
Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213-227 (2012).
-
(2012)
Cell
, vol.148
, pp. 213-227
-
-
Sun, L.1
-
82
-
-
33845865825
-
Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment
-
Yu, H., Kortylewski, M. & Pardoll, D. Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nature Rev. Immunol. 7, 41-51 (2007).
-
(2007)
Nature Rev. Immunol
, vol.7
, pp. 41-51
-
-
Yu, H.1
Kortylewski, M.2
Pardoll, D.3
-
83
-
-
38949165127
-
Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
-
Ding, B. B. et al. Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas. Blood 111, 1515-1523 (2008).
-
(2008)
Blood
, vol.111
, pp. 1515-1523
-
-
Ding, B.B.1
-
84
-
-
70350500225
-
STATs in cancer inflammation and immunity: A leading role for STAT3
-
Yu, H., Pardoll, D. & Jove, R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nature Rev. Cancer 9, 798-809 (2009).
-
(2009)
Nature Rev. Cancer
, vol.9
, pp. 798-809
-
-
Yu, H.1
Pardoll, D.2
Jove, R.3
-
85
-
-
0033783522
-
Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation
-
Liu, Y. et al. Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. J. Clin. Invest. 106, 951-961 (2000).
-
(2000)
J. Clin. Invest
, vol.106
, pp. 951-961
-
-
Liu, Y.1
-
86
-
-
84866487978
-
S1P1 inhibits sprouting angiogenesis during vascular development
-
Shoham, A. B. et al. S1P1 inhibits sprouting angiogenesis during vascular development. Development 139, 3859-3869 (2012).
-
(2012)
Development
, vol.139
, pp. 3859-3869
-
-
Shoham, A.B.1
-
87
-
-
84866044722
-
The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2
-
Gaengel, K. et al. The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. Dev. Cell 23, 587-599 (2012).
-
(2012)
Dev. Cell
, vol.23
, pp. 587-599
-
-
Gaengel, K.1
-
88
-
-
84866025219
-
Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development
-
Jung, B. et al. Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development. Dev. Cell 23, 600-610 (2012).
-
(2012)
Dev. Cell
, vol.23
, pp. 600-610
-
-
Jung, B.1
-
89
-
-
63649143900
-
Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis
-
Ishii, M. et al. Sphingosine-1-phosphate mobilizes osteoclast precursors and regulates bone homeostasis. Nature 458, 524-528 (2009).
-
(2009)
Nature
, vol.458
, pp. 524-528
-
-
Ishii, M.1
-
90
-
-
78650413566
-
Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo
-
Ishii, M., Kikuta, J., Shimazu, Y., Meier-Schellersheim, M. & Germain, R. N. Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo. J. Exp. Med. 207, 2793-2798 (2010).
-
(2010)
J. Exp. Med
, vol.207
, pp. 2793-2798
-
-
Ishii, M.1
Kikuta, J.2
Shimazu, Y.3
Meier-Schellersheim, M.4
Germain, R.N.5
-
91
-
-
84876864069
-
Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D
-
Kikuta, J. et al. Sphingosine-1-phosphate-mediated osteoclast precursor monocyte migration is a critical point of control in antibone-resorptive action of active vitamin D. Proc. Natl Acad. Sci. USA 110, 7009-7013 (2013).
-
(2013)
Proc. Natl Acad. Sci. USA
, vol.110
, pp. 7009-7013
-
-
Kikuta, J.1
-
92
-
-
78149277336
-
Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells
-
Long, J. S. et al. Sphingosine 1-phosphate receptor 4 uses HER2 (ERBB2) to regulate extracellular signal regulated kinase-1/2 in MDA-MB-453 breast cancer cells. J. Biol. Chem. 285, 35957-35966 (2010).
-
(2010)
J. Biol. Chem
, vol.285
, pp. 35957-35966
-
-
Long, J.S.1
-
93
-
-
84865987259
-
Selectivity and specificity of sphingosine-1-phosphate receptor ligands: Caveats and critical thinking in characterizing receptor-mediated effects
-
Salomone, S. & Waeber, C. Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects. Front. Pharmacol. 2, 9 (2011).
-
(2011)
Front. Pharmacol
, vol.2
, pp. 9
-
-
Salomone, S.1
Waeber, C.2
-
94
-
-
33646117016
-
Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: The role of sphingosine kinase-1
-
Sukocheva, O. et al. Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1. J. Cell Biol. 173, 301-310 (2006).
-
(2006)
J. Cell Biol
, vol.173
, pp. 301-310
-
-
Sukocheva, O.1
-
95
-
-
78149348826
-
High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients
-
Watson, C. et al. High expression of sphingosine 1-phosphate receptors, S1P1 and S1P3, sphingosine kinase 1, and extracellular signal-regulated kinase-1/2 is associated with development of tamoxifen resistance in estrogen receptor-positive breast cancer patients. Am. J. Pathol. 177, 2205-2215 (2010).
-
(2010)
Am. J. Pathol
, vol.177
, pp. 2205-2215
-
-
Watson, C.1
-
96
-
-
84859363534
-
In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody
-
Harris, G. L., Creason, M. B., Brulte, G. B. & Herr, D. R. In vitro and in vivo antagonism of a G protein-coupled receptor (S1P3) with a novel blocking monoclonal antibody. PLoS ONE 7, e35129 (2012).
-
(2012)
PLoS ONE
, vol.7
-
-
Harris, G.L.1
Creason, M.B.2
Brulte, G.B.3
Herr, D.R.4
-
97
-
-
77952327561
-
Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung
-
Sammani, S. et al. Differential effects of sphingosine 1-phosphate receptors on airway and vascular barrier function in the murine lung. Am. J. Respir. Cell. Mol. Biol. 43, 394-402 (2010).
-
(2010)
Am. J. Respir. Cell. Mol. Biol
, vol.43
, pp. 394-402
-
-
Sammani, S.1
-
98
-
-
41649094810
-
Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation
-
Niessen, F. et al. Dendritic cell PAR1-S1P3 signalling couples coagulation and inflammation. Nature 452, 654-658 (2008).
-
(2008)
Nature
, vol.452
, pp. 654-658
-
-
Niessen, F.1
-
99
-
-
84868328440
-
Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury
-
Sun, X. et al. Sphingosine-1-phosphate receptor-3 is a novel biomarker in acute lung injury. Am. J. Respir. Cell. Mol. Biol. 47, 628-636 (2012).
-
(2012)
Am. J. Respir. Cell. Mol. Biol
, vol.47
, pp. 628-636
-
-
Sun, X.1
-
100
-
-
80355129639
-
Sphingosine-1-phospate receptor 4 (S1P4) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model
-
Schulze, T. et al. Sphingosine-1-phospate receptor 4 (S1P4) deficiency profoundly affects dendritic cell function and TH17-cell differentiation in a murine model. FASEB J. 25, 4024-4036 (2011).
-
(2011)
FASEB J
, vol.25
, pp. 4024-4036
-
-
Schulze, T.1
-
101
-
-
79953190058
-
Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking
-
Allende, M. L. et al. Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking. J. Biol. Chem. 286, 7348-7358 (2011).
-
(2011)
J. Biol. Chem
, vol.286
, pp. 7348-7358
-
-
Allende, M.L.1
-
102
-
-
80051924460
-
SAR analysis of innovative selective small molecule antagonists of sphingosine-1-phosphate 4 (S1P4) receptor
-
Urbano, M. et al. SAR analysis of innovative selective small molecule antagonists of sphingosine-1-phosphate 4 (S1P4) receptor. Bioorg. Med. Chem. Lett. 21, 5470-5474 (2011).
-
(2011)
Bioorg. Med. Chem. Lett
, vol.21
, pp. 5470-5474
-
-
Urbano, M.1
-
103
-
-
70449732610
-
T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow
-
Jenne, C. N. et al. T-bet-dependent S1P5 expression in NK cells promotes egress from lymph nodes and bone marrow. J. Exp. Med. 206, 2469-2481 (2009).
-
(2009)
J. Exp. Med
, vol.206
, pp. 2469-2481
-
-
Jenne, C.N.1
-
104
-
-
77957660978
-
Design and synthesis of selective and potent orally active S1P5 agonists
-
Mattes, H. et al. Design and synthesis of selective and potent orally active S1P5 agonists. ChemMedChem 5, 1693-1696 (2010).
-
(2010)
ChemMedChem
, vol.5
, pp. 1693-1696
-
-
Mattes, H.1
-
105
-
-
84879172983
-
Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis
-
Yang, L. et al. Sphingosine kinase/sphingosine 1-phosphate (S1P)/S1P receptor axis is involved in liver fibrosis-associated angiogenesis. J. Hepatol. 59, 114-123 (2013).
-
(2013)
J. Hepatol
, vol.59
, pp. 114-123
-
-
Yang, L.1
-
106
-
-
70149120314
-
Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts
-
Kapitonov, D. et al. Targeting sphingosine kinase 1 inhibits Akt signaling, induces apoptosis, and suppresses growth of human glioblastoma cells and xenografts. Cancer Res. 69, 6915-6923 (2009).
-
(2009)
Cancer Res
, vol.69
, pp. 6915-6923
-
-
Kapitonov, D.1
-
107
-
-
84873409675
-
A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent mouse model of allergic asthma
-
Price, M. M. et al. A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent mouse model of allergic asthma. J. Allergy Clin. Immunol. 131, 501-511 (2012).
-
(2012)
J. Allergy Clin. Immunol
, vol.131
, pp. 501-511
-
-
Price, M.M.1
-
108
-
-
79954625512
-
A phase i clinical trial of safingol in combination with cisplatin in advanced solid tumors
-
Dickson, M. A. et al. A phase I clinical trial of safingol in combination with cisplatin in advanced solid tumors. Clin. Cancer Res. 17, 2484-2492 (2011).
-
(2011)
Clin. Cancer Res
, vol.17
, pp. 2484-2492
-
-
Dickson, M.A.1
-
109
-
-
84874670502
-
Characterization of isoenzyme-selective inhibitors of human sphingosine kinases
-
Gao, P., Peterson, Y. K., Smith, R. A. & Smith, C. D. Characterization of isoenzyme-selective inhibitors of human sphingosine kinases. PLoS ONE 7, e44543 (2012).
-
(2012)
PLoS ONE
, vol.7
-
-
Gao, P.1
Peterson, Y.K.2
Smith, R.A.3
Smith, C.D.4
-
110
-
-
79959498910
-
Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer
-
Antoon, J. W. et al. Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer. J. Mol. Endocrinol. 46, 205-216 (2011).
-
(2011)
J. Mol. Endocrinol
, vol.46
, pp. 205-216
-
-
Antoon, J.W.1
-
111
-
-
84864371831
-
Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats
-
Liu, Q. et al. Inhibition of sphingosine kinase-2 suppresses inflammation and attenuates graft injury after liver transplantation in rats. PLoS ONE 7, e41834 (2012).
-
(2012)
PLoS ONE
, vol.7
-
-
Liu, Q.1
-
112
-
-
79960731365
-
S1P is associated with protection in human and experimental cerebral malaria
-
Finney, C. A. et al. S1P is associated with protection in human and experimental cerebral malaria. Mol. Med. 17, 717-725 (2011).
-
(2011)
Mol. Med
, vol.17
, pp. 717-725
-
-
Finney, C.A.1
-
113
-
-
79955485953
-
STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma
-
Scuto, A. et al. STAT3 inhibition is a therapeutic strategy for ABC-like diffuse large B-cell lymphoma. Cancer Res. 71, 3182-3188 (2011).
-
(2011)
Cancer Res
, vol.71
, pp. 3182-3188
-
-
Scuto, A.1
-
114
-
-
84871968824
-
Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis
-
Saddoughi, S. A. et al. Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A-RIPK1-dependent necroptosis. EMBO Mol. Med. 5, 105-121 (2013).
-
(2013)
EMBO Mol. Med
, vol.5
, pp. 105-121
-
-
Saddoughi, S.A.1
-
115
-
-
19944432761
-
KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts
-
Shimizu, H. et al. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts. Circulation 111, 222-229 (2005).
-
(2005)
Circulation
, vol.111
, pp. 222-229
-
-
Shimizu, H.1
-
116
-
-
33344462470
-
Efficacy of mycophenolic acid combined with KRP-203, a novel immunomodulator, in a rat heart transplantation model
-
Suzuki, C. et al. Efficacy of mycophenolic acid combined with KRP-203, a novel immunomodulator, in a rat heart transplantation model. J. Heart Lung Transplant. 25, 302-309 (2006).
-
(2006)
J. Heart Lung Transplant
, vol.25
, pp. 302-309
-
-
Suzuki, C.1
-
117
-
-
37349056751
-
A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice
-
Song, J. et al. A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice. J. Pharmacol. Exp. Ther. 324, 276-283 (2008).
-
(2008)
J. Pharmacol. Exp. Ther
, vol.324
, pp. 276-283
-
-
Song, J.1
-
118
-
-
55249113624
-
Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist
-
Wenderfer, S. E., Stepkowski, S. M. & Braun, M. C. Increased survival and reduced renal injury in MRL/lpr mice treated with a novel sphingosine-1-phosphate receptor agonist. Kidney Int. 74, 1319-1326 (2008).
-
(2008)
Kidney Int
, vol.74
, pp. 1319-1326
-
-
Wenderfer, S.E.1
Stepkowski, S.M.2
Braun, M.C.3
-
119
-
-
84862509411
-
Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R/) mice
-
Poti, F. et al. Effect of sphingosine 1-phosphate (S1P) receptor agonists FTY720 and CYM5442 on atherosclerosis development in LDL receptor deficient (LDL-R/) mice. Vascul. Pharmacol. 57, 56-64 (2012).
-
(2012)
Vascul. Pharmacol
, vol.57
, pp. 56-64
-
-
Poti, F.1
-
120
-
-
71749087668
-
AUY954, a selective S1P1 modulator, prevents experimental autoimmune neuritis
-
Zhang, Z. Y. et al. AUY954, a selective S1P1 modulator, prevents experimental autoimmune neuritis. J. Neuroimmunol. 216, 59-65 (2009).
-
(2009)
J. Neuroimmunol
, vol.216
, pp. 59-65
-
-
Zhang, Z.Y.1
-
121
-
-
84866559134
-
A sphingosine-1-phosphate receptor 1-directed agonist reduces central nervous system inflammation in a plasmacytoid dendritic cell-dependent manner
-
Galicia-Rosas, G. et al. A sphingosine-1-phosphate receptor 1-directed agonist reduces central nervous system inflammation in a plasmacytoid dendritic cell-dependent manner. J. Immunol. 189, 3700-3706 (2012).
-
(2012)
J. Immunol
, vol.189
, pp. 3700-3706
-
-
Galicia-Rosas, G.1
-
122
-
-
33646525690
-
S1P1-selective agonist, SEW2871, ameliorates ischemic acute renal failure
-
Lien, Y. H., Yong, K. C., Cho, C., Igarashi, S. & Lai, L. W. S1P1-selective agonist, SEW2871, ameliorates ischemic acute renal failure. Kidney Int. 69, 1601-1608 (2006).
-
(2006)
Kidney Int
, vol.69
, pp. 1601-1608
-
-
Lien, Y.H.1
Yong, K.C.2
Cho, C.3
Igarashi, S.4
Lai, L.W.5
-
123
-
-
79955596917
-
Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes
-
Awad, A. S. et al. Chronic sphingosine 1-phosphate 1 receptor activation attenuates early-stage diabetic nephropathy independent of lymphocytes. Kidney Int. 79, 1090-1098 (2011).
-
(2011)
Kidney Int
, vol.79
, pp. 1090-1098
-
-
Awad, A.S.1
-
124
-
-
24944535833
-
S1P1-selective in vivo-active agonists from high-throughput screening: Off-The-shelf chemical probes of receptor interactions, signaling, and fate
-
Jo, E. et al. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. Chem. Biol. 12, 703-715 (2005).
-
(2005)
Chem. Biol
, vol.12
, pp. 703-715
-
-
Jo, E.1
-
125
-
-
79956068785
-
Discovery of CS-0777: A potent, selective, and orally active S1P1 agonist
-
Nishi, T. et al. Discovery of CS-0777: a potent, selective, and orally active S1P1 agonist. ACS Med. Chem. Lett. 2, 368-372 (2011).
-
(2011)
ACS Med. Chem. Lett
, vol.2
, pp. 368-372
-
-
Nishi, T.1
-
126
-
-
60849108052
-
A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection
-
Marsolais, D. et al. A critical role for the sphingosine analog AAL-R in dampening the cytokine response during influenza virus infection. Proc. Natl Acad. Sci. USA 106, 1560-1565 (2009).
-
(2009)
Proc. Natl Acad. Sci. USA
, vol.106
, pp. 1560-1565
-
-
Marsolais, D.1
-
127
-
-
84855366097
-
Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities
-
Fujii, Y. et al. Amelioration of collagen-induced arthritis by a novel S1P1 antagonist with immunomodulatory activities. J. Immunol. 188, 206-215 (2012).
-
(2012)
J. Immunol
, vol.188
, pp. 206-215
-
-
Fujii, Y.1
-
128
-
-
54349121551
-
Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-Like headgroup interactions
-
Gonzalez-Cabrera, P. J. et al. Full pharmacological efficacy of a novel S1P1 agonist that does not require S1P-Like headgroup interactions. Mol. Pharmacol. 74, 1308-1318 (2008).
-
(2008)
Mol. Pharmacol
, vol.74
, pp. 1308-1318
-
-
Gonzalez-Cabrera, P.J.1
-
129
-
-
15444373345
-
Sphingosine 1-phosphate analogs as receptor antagonists
-
Davis, M. D., Clemens, J. J., Macdonald, T. L. & Lynch, K. R. Sphingosine 1-phosphate analogs as receptor antagonists. J. Biol. Chem. 280, 9633-9641 (2005).
-
(2005)
J. Biol. Chem
, vol.280
, pp. 9633-9641
-
-
Davis, M.D.1
Clemens, J.J.2
MacDonald, T.L.3
Lynch, K.R.4
-
130
-
-
80054988629
-
The sphingosine-1-phosphate receptor-1 antagonist W146, causes early and short-lasting peripheral blood lymphopenia in mice
-
Tarrason, G. et al. The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice. Int. Immunopharmacol. 11, 1773-1779 (2011).
-
(2011)
Int. Immunopharmacol
, vol.11
, pp. 1773-1779
-
-
Tarrason, G.1
-
131
-
-
84872867676
-
Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism
-
Finley, A. et al. Sphingosine 1-phosphate mediates hyperalgesia via a neutrophil-dependent mechanism. PLoS ONE 8, e55255 (2013).
-
(2013)
PLoS ONE
, vol.8
-
-
Finley, A.1
-
132
-
-
84875723927
-
Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: Assessment of expression and role in cell migration
-
Kluk, M. J. et al. Sphingosine-1-phosphate receptor 1 in classical Hodgkin lymphoma: assessment of expression and role in cell migration. Lab. Invest. 93, 462-471 (2013).
-
(2013)
Lab. Invest
, vol.93
, pp. 462-471
-
-
Kluk, M.J.1
-
133
-
-
33845296479
-
Synthesis and biological evaluation of-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists
-
Foss, F. W. Jr et al. Synthesis and biological evaluation of-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists. Bioorg. Med. Chem. 15, 663-677 (2007).
-
(2007)
Bioorg. Med. Chem
, vol.15
, pp. 663-677
-
-
Foss Jr., F.W.1
-
134
-
-
78650866759
-
Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis
-
Skoura, A. et al. Sphingosine-1-phosphate receptor-2 function in myeloid cells regulates vascular inflammation and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 31, 81-85 (2011).
-
(2011)
Arterioscler. Thromb. Vasc. Biol
, vol.31
, pp. 81-85
-
-
Skoura, A.1
-
135
-
-
0037310755
-
Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5
-
Ikeda, H. et al. Antiproliferative property of sphingosine 1-phosphate in rat hepatocytes involves activation of Rho via Edg-5. Gastroenterology 124, 459-469 (2003).
-
(2003)
Gastroenterology
, vol.124
, pp. 459-469
-
-
Ikeda, H.1
-
136
-
-
77952693294
-
2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists
-
Bolli, M. H. et al. 2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonists. J. Med. Chem. 53, 4198-4211 (2010).
-
(2010)
J. Med. Chem
, vol.53
, pp. 4198-4211
-
-
Bolli, M.H.1
-
137
-
-
33644830810
-
Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages
-
Visentin, B. et al. Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9, 225-238 (2006).
-
(2006)
Cancer Cell
, vol.9
, pp. 225-238
-
-
Visentin, B.1
-
138
-
-
84888281434
-
Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization
-
Caballero, S. et al. Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization. Exp. Eye Res. (2008).
-
(2008)
Exp. Eye Res.
-
-
Caballero, S.1
-
139
-
-
80052542781
-
Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis
-
Sanada, Y. et al. Therapeutic effects of novel sphingosine-1-phosphate receptor agonist W-061 in murine DSS colitis. PLoS ONE 6, e23933 (2011).
-
(2011)
PLoS ONE
, vol.6
-
-
Sanada, Y.1
-
140
-
-
4444316123
-
Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: Discovery of potent, subtype-selective S1P4 receptor agonists
-
Clemens, J. J., Davis, M. D., Lynch, K. R. & Macdonald, T. L. Synthesis of benzimidazole based analogues of sphingosine-1-phosphate: discovery of potent, subtype-selective S1P4 receptor agonists. Bioorg. Med. Chem. Lett. 14, 4903-4906 (2004).
-
(2004)
Bioorg. Med. Chem. Lett
, vol.14
, pp. 4903-4906
-
-
Clemens, J.J.1
Davis, M.D.2
Lynch, K.R.3
MacDonald, T.L.4
-
141
-
-
85016365810
-
S1P4 receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs
-
Ota, H. et al. S1P4 receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs. Pulm. Circ. 1, 399-404 (2011).
-
(2011)
Pulm. Circ
, vol.1
, pp. 399-404
-
-
Ota, H.1
-
142
-
-
84856516517
-
Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation
-
Song, J., Hagiya, H., Kurata, H., Mizuno, H. & Ito, T. Prevention of GVHD and graft rejection by a new S1P receptor agonist, W-061, in rat small bowel transplantation. Transpl. Immunol. 26, 163-170 (2012).
-
(2012)
Transpl. Immunol
, vol.26
, pp. 163-170
-
-
Song, J.1
Hagiya, H.2
Kurata, H.3
Mizuno, H.4
Ito, T.5
|